MacroGenics, Inc

(NASDAQ:MGNX)

Latest On MacroGenics, Inc (MGNX):

Date/Time Type Description Signal Details
2023-05-29 12:24 ESTNewsMacroGenics: Non-Dilutive Funding Propels Drug Candidates (Rating Upgrade)N/A
2023-05-17 19:35 ESTNewsMacroGenics, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-10 04:57 ESTNewsMacroGenics GAAP EPS of -$0.61 misses by $1.20, revenue of $24.5M misses by $71.66MN/A
2023-05-10 04:57 ESTNewsMacroGenics, Inc. (MGNX) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 01:59 ESTNewsMacroGenics Q1 2023 Earnings PreviewN/A
2023-03-23 05:10 ESTNewsIncyte wins FDA nod for Zynyz to treat rare skin cancerN/A
2023-03-16 20:36 ESTNewsMacroGenics stock climbs ~10% as FY22 revenue rises beating estimatesN/A
2023-03-16 05:06 ESTNewsMacroGenics GAAP EPS of -$1.95 misses by $0.07, revenue of $151.94M beats by $1.88MN/A
2023-03-16 05:06 ESTNewsMacroGenics, Inc. (MGNX) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 23:01 ESTNewsMacroGenics expands license agreement with SynaffixN/A
2023-03-09 03:58 ESTNewsMacroGenics unloads TZIELD royalty stake for up to $200M to a unit of DRIN/A
2023-02-27 03:22 ESTNewsMacroGenics' Lorigerlimab Shows Promise In Metastatic Prostate Cancer TreatmentN/A
2023-02-13 22:27 ESTNewsMacroGenics phase 1 prostate cancer asset data leads to phase 2 initiation later in 2023N/A
2023-01-16 11:03 ESTNewsMacroGenics: Uncertain Revenue Casts A PallN/A
2022-11-23 16:19 ESTNewsMacroGenics cut to Neutral at Citi, Guggenheim upgradesN/A
2022-11-22 23:13 ESTNewsMacroGenics down 18% as Cowen downgrades on lack of catalystsN/A
2022-11-18 17:26 ESTNewsMacroGenics to get $60M milestone from Provention as FDA approves diabetes drug TzieldN/A
2022-11-06 11:13 ESTNewsMacroGenics, Inc. (MGNX) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 05:24 ESTNewsMacroGenics GAAP EPS of -$0.40 beats by $0.04, revenue of $41.73M beats by $12.45MN/A
2022-11-02 20:08 ESTNewsMacroGenics Q3 2022 Earnings PreviewN/A
2022-10-17 17:26 ESTNewsMacroGenics rises ~15% on licensing deal with Gilead for potential cancer treatmentN/A
2022-10-11 18:06 ESTNewsMacroGenics: No Near-Term CatalystsN/A
2022-09-02 18:48 ESTNewsIsrael Englander and his Millennium fund disclose 5.2% passive stake in MacroGenicsN/A
2022-08-09 05:06 ESTNewsMacroGenics GAAP EPS of -$0.67 beats by $0.30, revenue of $26.01M beats by $11.91MN/A
2022-08-09 05:05 ESTNewsMacroGenics, Inc. (MGNX) CEO Scott Koenig on Q2 2022 Results Earnings Call TranscriptN/A
2022-08-05 20:57 ESTNewsMacroGenics Q2 2022 Earnings PreviewN/A
2022-07-19 05:09 ESTNewsMacroGenics stock slips after SMBC Nikko downgrades to neutralN/A
2022-07-11 22:28 ESTNewsMacroGenics halts mid-stage head and neck cancer study after fatalitiesN/A
2022-07-11 22:28 ESTNewsMacroGenics downgraded at BMO after discontinuation of cancer trialN/A
2022-05-04 09:15 ESTNewsMacroGenics, Inc. (MGNX) CEO Scott Koenig on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 17:34 ESTNewsMacroGenics Non-GAAP EPS of -$1.08 misses by $0.23, revenue of $11.1M misses by $12.08MN/A
2022-05-02 23:15 ESTNewsMacroGenics Q1 2022 Earnings PreviewN/A
2022-02-28 15:19 ESTNewsMacroGenics promotes Eric Risser to COON/A
2022-02-28 15:19 ESTNewsMacroGenics upgraded to buy at Citi on valuationN/A
2022-02-25 11:09 ESTNewsMacroGenics GAAP EPS of -$3.37 misses by $0.10, revenue of $77.45M misses by $6.13MN/A
2022-02-25 11:09 ESTNewsMacroGenics, Inc. (MGNX) CEO Scott Canning on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 11:09 ESTNewsMacroGenics: Facing Considerable Headwinds From Unsatisfactory TrialsN/A
2022-02-03 14:19 ESTNewsSynaffix and MacroGenics collaborate for gen-ex ADCsN/A
2021-11-04 12:38 ESTNewsMacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 12:38 ESTNewsMacroGenics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-02 19:23 ESTNewsMacroGenics EPS misses by $0.19, misses on revenueN/A
2021-11-01 23:49 ESTNewsMacroGenics Q3 2021 Earnings PreviewN/A
2021-10-13 04:31 ESTNewsWarning: MGNX is at high risk of performing badlyN/A
2021-10-06 12:45 ESTNewsMGNX is at high risk of performing badlyN/A
2021-09-28 20:11 ESTNewsWarning: MGNX has been downgraded to Very BearishN/A
2021-09-28 20:11 ESTNewsI-Mab gets regulatory clearance in China for mid-stage solid tumor trialN/A
2021-09-22 00:18 ESTNewsMacroGenics' MGC018 shows encouraging anti-tumor activity in solid tumorsN/A
2021-09-22 00:18 ESTNewsMacroGenics' reports margetuximab + retifanlimab data in late-stage esophageal cancer studyN/A
2021-09-22 00:17 ESTNewsMacroGenics (MGNX) Investor Presentation - SlideshowN/A
2021-09-22 00:17 ESTNewsMacroGenics posts biggest one-day loss with mixed views from SVB Leerink on cancer trialN/A

About MacroGenics, Inc (MGNX):

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase II/III clinical trial for the treatment of breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; Enoblituzumab, a monoclonal antibody that targets B7-H3; and Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3. In addition, it is developing MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company's non-immuno-oncology clinical product candidates include MGD014, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. MacroGenics, Inc. has strategic collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

  • Name MacroGenics, Inc
  • Symbol MGNX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 370
  • Fiscal Year EndDecember
  • IPO Date2013-10-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.macrogenics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.1
  • Price/Book (Most Recent Quarter) 5.74
  • Enterprise Value Revenue 13.87
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.68
  • Next Year EPS Estimate -$2.19
  • Next Quarter EPS Estimate -$0.63
  • Profit Margin -124%
  • Operating Margin -125%
  • Return on Assets -24%
  • Return on Equity -49%
  • Revenue 104.88 million
  • Earnings Per Share -$3.47
  • Revenue Per Share $2
  • Gross Profit -88318000
  • Quarterly Earnings Growth 109.2%
View More

Highlights

  • Market Capitalization 1.76 billion
  • EBITDA -166046000
  • PE Ratio -1.61
  • PEG Ratio 0.01
  • Analyst Target Price $33.7
  • Book Value Per Share $5.26
View More

Share Statistics

  • Shares Outstanding 56.26 million
  • Shares Float 50.33 million
  • % Held by Insiders 284%
  • % Held by Institutions 97.26%
  • Shares Short 4.06 million
  • Shares Short Prior Month 3.93 million
  • Short Ratio 4.99
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.25
  • 52 Week High $32.18
  • 52 Week Low $4.56
  • 50 Day Moving Average 23.49
  • 200 Day Moving Average 23.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

MacroGenics, Inc (MGNX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MacroGenics, Inc (MGNX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$52.69 million-$0.04-$0.6093.33%
2020-09-302020-11-04$18.25 million-$0.66-$1.0235.17%
2020-06-302020-07-30$N/A-$0.94-$1.006.19%
2020-03-312020-05-05$13.68 million-$0.91-$1.0412.5%
2019-12-312020-02-25$25.19 million-$0.62-$1.1646.44%
2019-09-302019-11-06$18.74 million-$0.91-$1.1117.66%
2019-06-302019-07-31$10.59 million-$1.05-$1.071.69%
2019-03-312019-05-01$9.66 million-$0.99-$0.87-13.3%
2018-12-312019-02-26$15.79 million-$1.01-$0.96-4.8%
2018-09-302018-11-07$20.8 million-$0.81-$1.3037.84%
2018-06-302018-08-07$18.83 million-$1.03-$1.2114.64%
2018-03-312018-05-07$4.7 million-$1.34-$1.10-21.72%
2017-12-312018-02-27$152.36 million$2.96$2.6412.11%
2017-09-302017-11-08$1.66 million-$1.28-$1.04-22.91%
2017-06-302017-08-02$1.67 million-$1.14-$1.00-14.4%
2017-03-312017-05-03$2.06 million-$1.08-$0.91-18.81%
2016-12-312017-02-28$5.11 million-$1.00-$0.94-6.59%
2016-09-302016-11-02$3.26 million-$0.97-$0.83-16.95%
2016-06-302016-08-03$80.67 million$1.12-$0.62282%
2016-03-312016-05-04$2.85 million-$0.88-$0.68-30.22%
2015-12-312016-02-29$8.18 million-$0.88-$0.58-51.78%
2015-09-302015-11-04$14.68 million-$0.46-$0.26-76.92%
2015-06-302015-08-05$6.72 million-$0.71-$0.44-61.36%
2015-03-312015-05-06$71.28 million$1.42$1.46-2.74%
2014-12-312015-03-03$5.48 million-$0.69-$0.35-97.14%
2014-09-302014-11-11$18.38 million-$0.14-$0.4266.67%
2014-06-302014-08-05$9.22 million-$0.44-$0.29-51.72%
2014-03-312014-05-06$14.72 million-$0.12-$0.08-50%
2013-12-312014-03-20$14.91 million-$0.14-$0.2748.15%
2013-09-302013-11-12$20.23 million$0.01$0.19-94.74%

MacroGenics, Inc (MGNX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MacroGenics, Inc (MGNX) Chart:

MacroGenics, Inc (MGNX) News:

Below you will find a list of latest news for MacroGenics, Inc (MGNX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MacroGenics, Inc (MGNX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-1610.66CALL0 20TRUE00
2025-05-1620.1CALL1 35131.96FALSE0.051
2025-05-1630CALL0 00FALSE00
2025-05-1640CALL0 0307.13FALSE00
2025-05-1650CALL0 00FALSE00
2025-05-1610.05PUT0 30202.9FALSE00
2025-05-1621.27PUT0 55103.9TRUE00
2025-05-1630PUT0 0369.77TRUE00
2025-05-1640PUT0 0697.2TRUE00
2025-05-1650PUT0 0652.35TRUE00
2025-06-2010CALL0 0292.22TRUE00
2025-06-2020.2CALL9 31112.75FALSE0.20
2025-06-2030CALL0 00FALSE00
2025-06-2040CALL0 0255.83FALSE00
2025-06-2050CALL0 0287.57FALSE00
2025-06-2010PUT0 0140.4FALSE00
2025-06-2020PUT0 034.69TRUE00
2025-06-2030PUT0 0387.71TRUE00
2025-06-2040PUT0 0336.63TRUE00
2025-06-2050PUT0 0331.49TRUE00
2025-07-1812.8CALL0 00TRUE00
2025-07-1821.1CALL0 589.97FALSE00
2025-07-1830.34CALL0 50FALSE00
2025-07-1840.5CALL0 220FALSE00
2025-07-1850.13CALL0 47247.43FALSE00
2025-07-1860.17CALL0 6250.23FALSE00
2025-07-1870CALL0 0266FALSE00
2025-07-1880CALL0 0279.17FALSE00
2025-07-1810.05PUT0 10423.42FALSE00
2025-07-1820.82PUT0 32058.33TRUE00
2025-07-1832.05PUT0 101421.53TRUE00
2025-07-1840PUT0 0368.56TRUE00
2025-07-1850PUT0 0179.09TRUE00
2025-07-1860PUT0 0258.1TRUE00
2025-07-1870PUT0 0215.93TRUE00
2025-07-1880PUT0 0230.15TRUE00
2025-10-1710CALL0 00TRUE00
2025-10-1720.4CALL0 190FALSE00
2025-10-1730.3CALL0 990FALSE00
2025-10-1740CALL0 0114.81FALSE00
2025-10-1750CALL0 00FALSE00
2025-10-1760CALL0 00FALSE00
2025-10-1710PUT0 0101.1FALSE00
2025-10-1720.35PUT0 6053.27TRUE00
2025-10-1730PUT0 0353.98TRUE00
2025-10-1740PUT0 0117.84TRUE00
2025-10-1750PUT0 0190.4TRUE00
2025-10-1760PUT0 0719.18TRUE00
2025-12-1910.8CALL1 262.27TRUE0.80
2025-12-192.50.4CALL3 299108.8FALSE0.40
2025-12-1940CALL0 00FALSE00
2025-12-1950.08CALL0 284128.16FALSE00
2025-12-197.50.4CALL0 36114.46FALSE00
2025-12-19100.52CALL0 86179.09FALSE00
2025-12-1912.50.05CALL0 13210.66FALSE00
2025-12-19150CALL0 0220.11FALSE00
2025-12-1917.50CALL0 0227.87FALSE00
2025-12-19200CALL0 0234.42FALSE00
2025-12-1922.50CALL0 0240.09FALSE00
2025-12-19250CALL0 0245.08FALSE00
2025-12-19300.7CALL0 10253.52FALSE00
2025-12-1910.2PUT0 195.8FALSE00
2025-12-192.50.8PUT0 481134.2TRUE00
2025-12-1942.7PUT0 20138.87TRUE00
2025-12-1953.44PUT0 1184.36TRUE00
2025-12-197.50PUT0 0156.2TRUE00
2025-12-19108.3PUT0 0164.51TRUE00
2025-12-1912.510.35PUT0 0180.73TRUE00
2025-12-191510.9PUT0 0249.12TRUE00
2025-12-1917.50PUT0 0218.76TRUE00
2025-12-19200PUT0 0215.83TRUE00
2025-12-1922.50PUT0 0238.34TRUE00
2025-12-19250PUT0 0233.2TRUE00
2025-12-19300PUT0 0461.9TRUE00

Latest MGNX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST200$2.435
Jun 13, 2022 7:59 PM EST300$2.435
Jun 13, 2022 7:59 PM EST100$2.435
Jun 13, 2022 7:59 PM EST143$2.435
Jun 13, 2022 7:59 PM EST100$2.435

MacroGenics, Inc (MGNX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000108/0001125345-20-000108-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1125345/000000000019016190/0000000000-19-016190-index.htm
2019-12-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1125345/000000000019016747/0000000000-19-016747-index.htm
2019-12-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1125345/000000000019016873/0000000000-19-016873-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000008025519002647/0000080255-19-002647-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000008025520001252/0000080255-20-001252-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000021545719004794/0000215457-19-004794-index.htm
2018-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000031506618002547/0000315066-18-002547-index.htm
2019-01-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000072888919000096/0000728889-19-000096-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000083423720005801/0000834237-20-005801-index.htm
2020-08-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000089914020000366/0000899140-20-000366-index.htm
2019-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000090445419000073/0000904454-19-000073-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000091420820000214/0000914208-20-000214-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000093247119005574/0000932471-19-005574-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000110465920018668/0001104659-20-018668-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000059/0001125345-18-000059-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000068/0001125345-18-000068-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000069/0001125345-18-000069-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000070/0001125345-18-000070-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000071/0001125345-18-000071-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000072/0001125345-18-000072-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000073/0001125345-18-000073-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000074/0001125345-18-000074-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000075/0001125345-18-000075-index.htm
2018-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000077/0001125345-18-000077-index.htm
2018-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000079/0001125345-18-000079-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534518000084/0001125345-18-000084-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000085/0001125345-18-000085-index.htm
2018-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000088/0001125345-18-000088-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534518000097/0001125345-18-000097-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000099/0001125345-18-000099-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000101/0001125345-18-000101-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000103/0001125345-18-000103-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000105/0001125345-18-000105-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000107/0001125345-18-000107-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000109/0001125345-18-000109-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534518000111/0001125345-18-000111-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000002/0001125345-19-000002-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000004/0001125345-19-000004-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000006/0001125345-19-000006-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000008/0001125345-19-000008-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000010/0001125345-19-000010-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000012/0001125345-19-000012-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000016/0001125345-19-000016-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000017/0001125345-19-000017-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000018/0001125345-19-000018-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000027/0001125345-19-000027-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000028/0001125345-19-000028-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000029/0001125345-19-000029-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000030/0001125345-19-000030-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000031/0001125345-19-000031-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000032/0001125345-19-000032-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000033/0001125345-19-000033-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000034/0001125345-19-000034-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000044/0001125345-19-000044-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/0001125345-19-000046-index.htm
2019-03-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000048/0001125345-19-000048-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000050/0001125345-19-000050-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534519000059/0001125345-19-000059-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000061/0001125345-19-000061-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000063/0001125345-19-000063-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000072/0001125345-19-000072-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000073/0001125345-19-000073-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000074/0001125345-19-000074-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000075/0001125345-19-000075-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000076/0001125345-19-000076-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000077/0001125345-19-000077-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000078/0001125345-19-000078-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000079/0001125345-19-000079-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000081/0001125345-19-000081-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000083/0001125345-19-000083-index.htm
2019-06-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000088/0001125345-19-000088-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000091/0001125345-19-000091-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000097/0001125345-19-000097-index.htm
2019-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534519000098/0001125345-19-000098-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000100/0001125345-19-000100-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000103/0001125345-19-000103-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534519000112/0001125345-19-000112-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000114/0001125345-19-000114-index.htm
2019-12-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1125345/000112534519000119/0001125345-19-000119-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000003/0001125345-20-000003-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000005/0001125345-20-000005-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000007/0001125345-20-000007-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000009/0001125345-20-000009-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000011/0001125345-20-000011-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000020/0001125345-20-000020-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000021/0001125345-20-000021-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000022/0001125345-20-000022-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000023/0001125345-20-000023-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000024/0001125345-20-000024-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000025/0001125345-20-000025-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000026/0001125345-20-000026-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000027/0001125345-20-000027-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/0001125345-20-000031-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000033/0001125345-20-000033-index.htm
2020-03-0210-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1125345/000112534520000036/0001125345-20-000036-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000038/0001125345-20-000038-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000042/0001125345-20-000042-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000044/0001125345-20-000044-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000046/0001125345-20-000046-index.htm
2020-03-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000051/0001125345-20-000051-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000055/0001125345-20-000055-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000057/0001125345-20-000057-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000059/0001125345-20-000059-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000064/0001125345-20-000064-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000065/0001125345-20-000065-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534520000072/0001125345-20-000072-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000073/0001125345-20-000073-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000077/0001125345-20-000077-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000079/0001125345-20-000079-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000087/0001125345-20-000087-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000088/0001125345-20-000088-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000089/0001125345-20-000089-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000090/0001125345-20-000090-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000091/0001125345-20-000091-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000092/0001125345-20-000092-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000093/0001125345-20-000093-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000096/0001125345-20-000096-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000098/0001125345-20-000098-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000100/0001125345-20-000100-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000103/0001125345-20-000103-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000106/0001125345-20-000106-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000108/0001125345-20-000108-index.htm
2020-07-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000113/0001125345-20-000113-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000114/0001125345-20-000114-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000115/0001125345-20-000115-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000116/0001125345-20-000116-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534520000126/0001125345-20-000126-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000127/0001125345-20-000127-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000129/0001125345-20-000129-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000131/0001125345-20-000131-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000133/0001125345-20-000133-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000136/0001125345-20-000136-index.htm
2020-09-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000138/0001125345-20-000138-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000141/0001125345-20-000141-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000143/0001125345-20-000143-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000112534520000150/0001125345-20-000150-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1125345/000112534520000152/0001125345-20-000152-index.htm
2019-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1125345/000114036119002949/0001140361-19-002949-index.htm
2019-02-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1125345/000114036119003061/0001140361-19-003061-index.htm
2019-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000114036119003314/0001140361-19-003314-index.htm
2019-12-23S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1125345/000114036119023104/0001140361-19-023104-index.htm
2019-12-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1125345/000114036119023506/0001140361-19-023506-index.htm
2020-01-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1125345/000114036120000211/0001140361-20-000211-index.htm
2020-02-20SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000114036120003712/0001140361-20-003712-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000114036120004828/0001140361-20-004828-index.htm
2020-06-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1125345/000114036120014347/0001140361-20-014347-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1125345/000114036120014355/0001140361-20-014355-index.htm
2020-11-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1125345/000114036120024552/0001140361-20-024552-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000119312519037855/0001193125-19-037855-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000119312519040794/0001193125-19-040794-index.htm
2019-04-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1125345/000119312519099226/0001193125-19-099226-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000119312520037822/0001193125-20-037822-index.htm
2019-05-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000131924419000050/0001319244-19-000050-index.htm
2020-02-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1125345/000131924420000028/0001319244-20-000028-index.htm
2020-01-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1125345/999999999520000017/9999999995-20-000017-index.htm
2018-05-14CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1125345/999999999718005677/9999999997-18-005677-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1125345/999999999719001401/9999999997-19-001401-index.htm
2019-08-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1125345/999999999719006383/9999999997-19-006383-index.htm

MacroGenics, Inc (MGNX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MacroGenics, Inc (MGNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 284%
Institutional Ownership: 9726%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-02Jeffrey Stuart PetersGeneral CounselSell202.0030.006,060.000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000116/0001125345-20-000116-index.htm
2020-09-09Kenneth GalbraithDirectorSell13,849.0027.11375,446.390.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000133/0001125345-20-000133-index.htm
2019-02-06Thomas SpitznagelSr VP, BPD & ManufacturingSell1,770.0030.0053,100.000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000016/0001125345-19-000016-index.htm
2020-05-20Thomas SpitznagelSr VP, BPD & ManufacturingSell7,500.0025.30189,750.000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000098/0001125345-20-000098-index.htm
2020-08-20Thomas SpitznagelSr VP, BPD & ManufacturingSell7,500.0026.87201,525.000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000129/0001125345-20-000129-index.htm
2020-09-17Ezio BonviniSr VP, Research & CSOSell44,512.0029.881,330,018.56102,146.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000136/0001125345-20-000136-index.htm
2018-11-27James KarrelsSVP, CFO and SecretaryBuy3,000.000.942,820.00117,847.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000105/0001125345-18-000105-index.htm
2018-10-22Eric Blasius RisserSr VP & Chief Business OfficerBuy3,000.000.942,820.0012,100.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000088/0001125345-18-000088-index.htm
2018-12-18James KarrelsSVP, CFO and SecretaryBuy5,000.000.944,700.00122,847.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000111/0001125345-18-000111-index.htm
2019-01-08James KarrelsSVP, CFO and SecretaryBuy5,314.000.944,995.16128,161.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000004/0001125345-19-000004-index.htm
2019-01-24James KarrelsSVP, CFO and SecretaryBuy5,326.000.945,006.44133,487.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000008/0001125345-19-000008-index.htm
2019-01-24James KarrelsSVP, CFO and SecretaryBuy2,000.000.941,880.00135,487.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000008/0001125345-19-000008-index.htm
2020-09-09Kenneth GalbraithDirectorBuy13,849.0016.00221,584.0013,849.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000133/0001125345-20-000133-index.htm
2020-01-30James KarrelsSVP, CFO and SecretaryBuy7,320.000.946,880.80142,807.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000005/0001125345-20-000005-index.htm
2020-01-30James KarrelsSVP, CFO and SecretaryBuy5,180.000.944,869.20147,987.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000005/0001125345-20-000005-index.htm
2020-03-06James KarrelsSVP, CFO and SecretaryBuy4,473.000.944,204.62152,460.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000038/0001125345-20-000038-index.htm
2018-11-13Eric Blasius RisserSr VP & Chief Business OfficerBuy4,000.000.943,760.0016,100.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000103/0001125345-18-000103-index.htm
2018-11-13Scott KoenigPresident and CEOBuy40,000.000.9437,600.00173,163.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000101/0001125345-18-000101-index.htm
2019-02-06Thomas SpitznagelSr VP, BPD & ManufacturingBuy1,770.007.5113,292.701,770.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000016/0001125345-19-000016-index.htm
2019-02-06Jeffrey Stuart PetersGeneral CounselSell68.0030.002,040.00202.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000017/0001125345-19-000017-index.htm
2019-01-03Scott KoenigPresident and CEOBuy39,897.000.9437,503.18213,060.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000002/0001125345-19-000002-index.htm
2018-12-12Eric Blasius RisserSr VP & Chief Business OfficerBuy5,000.000.944,700.0022,309.00https://www.sec.gov/Archives/edgar/data/1125345/000112534518000109/0001125345-18-000109-index.htm
2019-01-28Eric Blasius RisserSr VP & Chief Business OfficerBuy6,000.000.945,640.0028,309.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000010/0001125345-19-000010-index.htm
2019-03-14Eric Blasius RisserSr VP & Chief Business OfficerBuy2,497.000.942,347.1830,806.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000050/0001125345-19-000050-index.htm
2019-05-20Eric Blasius RisserSr VP & Chief Business OfficerSell3,000.0018.3855,131.0030,806.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000083/0001125345-19-000083-index.htm
2019-05-22Eric Blasius RisserSr VP & Chief Business OfficerSell1,000.0019.0319,026.0030,806.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000083/0001125345-19-000083-index.htm
2019-05-22Eric Blasius RisserSr VP & Chief Business OfficerBuy1,000.000.94940.0031,806.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000083/0001125345-19-000083-index.htm
2019-09-27Eric Blasius RisserSr VP & Chief Business OfficerBuy1,662.000.941,562.2832,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000100/0001125345-19-000100-index.htm
2020-02-04Eric Blasius RisserSr VP & Chief Business OfficerSell30.0010.00300.0032,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000009/0001125345-20-000009-index.htm
2020-02-05Eric Blasius RisserSr VP & Chief Business OfficerSell623.0010.006,230.0032,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000009/0001125345-20-000009-index.htm
2020-02-20Eric Blasius RisserSr VP & Chief Business OfficerSell500.0010.845,420.0032,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000011/0001125345-20-000011-index.htm
2020-02-04Eric Blasius RisserSr VP & Chief Business OfficerBuy30.000.9428.2032,498.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000009/0001125345-20-000009-index.htm
2020-02-20Eric Blasius RisserSr VP & Chief Business OfficerBuy500.000.94470.0032,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000011/0001125345-20-000011-index.htm
2020-02-05Eric Blasius RisserSr VP & Chief Business OfficerBuy623.000.94585.6233,091.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000009/0001125345-20-000009-index.htm
2019-05-20Eric Blasius RisserSr VP & Chief Business OfficerBuy3,000.000.942,820.0033,806.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000083/0001125345-19-000083-index.htm
2020-03-13Eric Blasius RisserSr VP & Chief Business OfficerBuy6,000.000.945,640.0038,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000046/0001125345-20-000046-index.htm
2020-04-16Eric Blasius RisserSr VP & Chief Business OfficerBuy6,000.000.945,640.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000059/0001125345-20-000059-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerSell3,532.0025.0088,300.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-05-26Eric Blasius RisserSr VP & Chief Business OfficerSell500.0026.5913,295.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000100/0001125345-20-000100-index.htm
2020-06-24Eric Blasius RisserSr VP & Chief Business OfficerSell500.0028.4914,245.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000108/0001125345-20-000108-index.htm
2020-07-02Eric Blasius RisserSr VP & Chief Business OfficerSell3,100.0030.0093,000.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000115/0001125345-20-000115-index.htm
2020-07-27Eric Blasius RisserSr VP & Chief Business OfficerSell489.0025.1312,288.5744,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2020-07-27Eric Blasius RisserSr VP & Chief Business OfficerSell3,000.0025.6376,890.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2020-08-26Eric Blasius RisserSr VP & Chief Business OfficerSell500.0027.1013,549.5044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000131/0001125345-20-000131-index.htm
2020-09-28Eric Blasius RisserSr VP & Chief Business OfficerSell500.0025.3312,665.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000138/0001125345-20-000138-index.htm
2020-10-28Eric Blasius RisserSr VP & Chief Business OfficerSell1,500.0020.6931,035.0044,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000143/0001125345-20-000143-index.htm
2020-07-27Eric Blasius RisserSr VP & Chief Business OfficerBuy489.000.94459.6644,957.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerBuy500.000.94470.0044,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-05-26Eric Blasius RisserSr VP & Chief Business OfficerBuy500.000.94470.0044,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000100/0001125345-20-000100-index.htm
2020-06-24Eric Blasius RisserSr VP & Chief Business OfficerBuy500.000.94470.0044,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000108/0001125345-20-000108-index.htm
2020-08-26Eric Blasius RisserSr VP & Chief Business OfficerBuy500.001.51755.0044,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000131/0001125345-20-000131-index.htm
2020-09-28Eric Blasius RisserSr VP & Chief Business OfficerBuy500.001.51755.0044,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000138/0001125345-20-000138-index.htm
2020-10-28Eric Blasius RisserSr VP & Chief Business OfficerBuy1,500.001.512,265.0045,968.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000143/0001125345-20-000143-index.htm
2020-07-27Eric Blasius RisserSr VP & Chief Business OfficerSell1,000.0025.1425,140.0047,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2020-07-02Eric Blasius RisserSr VP & Chief Business OfficerBuy3,100.001.514,681.0047,568.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000115/0001125345-20-000115-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerSell3,000.0020.0060,000.0048,000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-07-27Eric Blasius RisserSr VP & Chief Business OfficerBuy4,000.001.516,040.0048,468.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000118/0001125345-20-000118-index.htm
2019-02-06Matthew K FustDirectorSell6,924.0029.38203,427.12500.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000018/0001125345-19-000018-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerSell1,000.0015.0015,000.0051,000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerSell500.0010.005,000.0052,000.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-05-06Eric Blasius RisserSr VP & Chief Business OfficerBuy7,532.001.5111,373.3252,500.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000075/0001125345-20-000075-index.htm
2020-09-09Kenneth GalbraithDirectorBuy6,924.0020.15139,518.606,924.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000133/0001125345-20-000133-index.htm
2019-02-06Matthew K FustDirectorBuy6,924.0020.15139,518.607,424.00https://www.sec.gov/Archives/edgar/data/1125345/000112534519000018/0001125345-19-000018-index.htm
2020-05-20Thomas SpitznagelSr VP, BPD & ManufacturingBuy7,500.007.5156,325.007,500.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000098/0001125345-20-000098-index.htm
2020-08-20Thomas SpitznagelSr VP, BPD & ManufacturingBuy7,500.007.5156,325.007,500.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000129/0001125345-20-000129-index.htm
2020-09-18Ezio BonviniSr VP, Research & CSOSell18,339.0032.00586,848.0083,807.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000136/0001125345-20-000136-index.htm
2020-03-11Scott KoenigPresident and CEOBuy133,163.000.94125,173.22943,103.00https://www.sec.gov/Archives/edgar/data/1125345/000112534520000044/0001125345-20-000044-index.htm